Cambrex, manufacturer of small molecule active pharmaceutical ingredients (APIs), has announced it is investing in new capacity and continuous flow technology at its Karlskoga facility in Sweden. The investment includes
Tag "active pharmaceutical ingredients"
Advertisements
